Screener
Disc Medicine IRON Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by Disc Medicine in its filing.
Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.
The source filing: Disc Medicine’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 8:33 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-205192
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $88,913 | $91,145 |
| Marketable securities | 641,245 | 700,007 |
| Prepaid expenses and other current assets | 17,297 | 12,746 |
| Total current assets | 747,455 | 803,898 |
| Property and equipment, net | 1,070 | 1,159 |
| Right-of-use assets, operating leases | 967 | 1,096 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Disc Medicine's cash & equivalents?
- Disc Medicine (IRON) reported cash & equivalents of $88.91M in Q1 2026.
- How has Disc Medicine's cash & equivalents changed year-over-year?
- Disc Medicine's cash & equivalents decreased by 27.5% year-over-year, from $122.68M to $88.91M.
- What is the long-term trend for Disc Medicine's cash & equivalents?
- Over 5 years (2020 to 2025), Disc Medicine's cash & equivalents has grown at a 82.5% compound annual growth rate (CAGR), from $4.5M to $91.15M.
- What does cash & equivalents mean?
- Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.
Ask your AI about Disc Medicine's cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude